Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells

被引:1
作者
Pietrobono, Deborah [1 ]
Russo, Lara [1 ]
Bertilacchi, Maria Sofia [1 ]
Marchetti, Laura [1 ]
Martini, Claudia [1 ]
Giacomelli, Chiara [1 ]
Trincavelli, Maria Letizia [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
关键词
adenosine; glioblastoma; mesenchymal stem cells (MSC); purine metabolism; tumor microenvironment (TME); HIF-1-DEPENDENT REPRESSION; EXPRESSION; GLIOMA; RECEPTORS; DIFFERENTIATION; CLASSIFICATION; PROLIFERATION; OSTEOBLASTS; DEAMINASE; TUMORS;
D O I
10.1002/iub.2905
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma (GB) is a lethal brain tumor that rapidly adapts to the dynamic changes of the tumor microenvironment (TME). Mesenchymal stem/stromal cells (MSCs) are one of the stromal components of the TME playing multiple roles in tumor progression. GB progression is prompted by the immunosuppressive microenvironment characterized by high concentrations of the nucleoside adenosine (ADO). ADO acts as a signaling molecule through adenosine receptors (ARs) but also as a genetic and metabolic regulator. Herein, the effects of high extracellular ADO concentrations were investigated in a human glioblastoma cellular model (U343MG) and MSCs. The modulation of the purinome machinery, i.e., the ADO production (CD39, CD73, and adenosine kinase [ADK]), transport (equilibrative nucleoside transporters 1 (ENT1) and 2 (ENT2)), and degradation (adenosine deaminase [ADA]) were investigated in both cell lines to evaluate if ADO could affect its cell management in a positive or negative feed-back loop. Results evidenced a different behavior of GB and MSC cells upon exposure to high extracellular ADO levels: U343MG were less sensitive to the ADO concentration and only a slight increase in ADK and ENT1 was evidenced. Conversely, in MSCs, the high extracellular ADO levels reduced the ADK, ENT1, and ENT2 expression, which further sustained the increase of extracellular ADO. Of note, MSCs primed with the GB-conditioned medium or co-cultured with U343MG cells were not affected by the increase of extracellular ADO. These results evidenced how long exposure to ADO could produce different effects on cancer cells with respect to MSCs, revealing a negative feedback loop that can support the GB immunosuppressive microenvironment. These results improve the knowledge of the ADO role in the maintenance of TME, which should be considered in the development of therapeutic strategies targeting adenosine pathways as well as cell-based strategies using MSCs.
引用
收藏
页码:1234 / 1251
页数:18
相关论文
共 89 条
[1]   Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells [J].
Alarcon, Sebastian ;
de los Angeles Toro, Maria ;
Villarreal, Carolina ;
Melo, Romulo ;
Fernandez, Rodrigo ;
Ayuso Sacido, Angel ;
Uribe, Daniel ;
San Martin, Rody ;
Quezada, Claudia .
CELLS, 2020, 9 (08)
[2]   Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies [J].
Antunes, Ana Rita Pombo ;
Scheyltjens, Isabelle ;
Duerinck, Johnny ;
Neyns, Bart ;
Movahedi, Kiavash ;
Van Ginderachter, Jo A. .
ELIFE, 2020, 9
[3]   Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment [J].
Arab, Samaneh ;
Alizadeh, Akram ;
Asgharzade, Samira .
CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (02) :205-213
[4]  
Atala A, 2016, J UROLOGY, V196, P1817, DOI [10.1016/j.juro.2016.09.014, 10.1002/stem.2412]
[5]   Blockade of CD73 delays glioblastoma growth by modulating the immune environment [J].
Azambuja, J. H. ;
Schuh, R. S. ;
Michels, L. R. ;
Iser, I. C. ;
Beckenkamp, L. R. ;
Roliano, G. G. ;
Lenz, G. S. ;
Scholl, J. N. ;
Sevigny, J. ;
Wink, M. R. ;
Stefani, M. A. ;
Battastini, A. M. O. ;
Figueiro, F. ;
Teixeira, H. F. ;
Braganhol, E. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (09) :1801-1812
[6]   Tumor microenvironment complexity and therapeutic implications at a glance [J].
Baghba, Roghayyeh ;
Roshangar, Leila ;
Jahanban-Esfahlan, Rana ;
Seidi, Khaled ;
Ebrahimi-Kalan, Abbas ;
Jaymand, Mehdi ;
Kolahian, Saeed ;
Javaheri, Tahereh ;
Zare, Peyman .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[7]   Cross talkbetween mesenchymal and glioblastoma stem cells: Communication beyond controversies [J].
Bajetto, Adriana ;
Thellung, Stefano ;
Dellacasagrande, Irene ;
Pagano, Aldo ;
Barbieri, Federica ;
Florio, Tullio .
STEM CELLS TRANSLATIONAL MEDICINE, 2020, 9 (11) :1310-1330
[8]   Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice [J].
Bao, Rui ;
Shui, Xianqi ;
Hou, Jiong ;
Li, Jinbao ;
Deng, Xiaoming ;
Zhu, Xiaoyan ;
Yang, Tao .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (03) :969-975
[9]   Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters [J].
Barresi, Elisabetta ;
Giacomelli, Chiara ;
Marchetti, Laura ;
Baglini, Emma ;
Salerno, Silvia ;
Greco, Giovanni ;
Settimo, Federico ;
Martini, Claudia ;
Trincavelli, Maria Letizia ;
Taliani, Sabrina .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) :286-294
[10]   The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation [J].
Bavaresco, Luci ;
Bernardi, Andressa ;
Braganhol, Elizandra ;
Cappellari, Angelica Regina ;
Rockenbach, Liliana ;
Farias, Patricia Fernandes ;
Wink, Marcia Rosangela ;
Delgado-Canedo, Andres ;
Oliveira Battastini, Ana Maria .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 319 (1-2) :61-68